StockDuty ← Dashboard Sep 16, 2026 08:25 AM ET
SignalMacro

Leqembi® Pen subcutaneous formulation approved in Japan

Leqembi subcutaneous approval in Japan expands treatment access.

Leqembi subcutaneous approval in Japan expands treatment access.
Leqembi subcutaneous approval in Japan expands treatment access. — impact context not separately stored; see What changed.
Sources